Analytical Stability Indicative Method Development and Validation by High Pressure Liquid Chromatography for Assay in Ciprofloxacin hydrochloride Drug Substances


Ciprofloxacin is an antibiotic generic drug that can treat a number of bacterial infections. It is a second generic fluoroquinolone. This work presents a simple, sensitive and stability indicative method for assay determination of drug substances ciprofloxacin hydrochloride by high pressure liquid chromatography (HPLC). Separation of impurities from the main drug substances and accurate assay quantification with a simple method is difficult by Spectrophotometry. The separation of co-eluents and impurities from the ciprofloxacin drug substances was archived by HPLC with simple mobile phase 0.15% orthophosphoric acid adjusted pH to 3.0 with triethylamine and acetonitrile using a gradient program, column inertsil C18, 250 mm × 4.0 mm, 5 μm. Flow rate was 0.7 mL/min, the column temperature and injection volume were 35°C and 10.0 μL. Chromato-graphic analysis was carried out at wavelength 278 nm. The developed method was validated according to the international conference on harmonization (ICH) guidelines regarding: Precision, specificity by degradation, linearity, accuracy, range and robustness. The proposed method showed good linearity (correlation coefficient and regression coefficient were not less than 0.999 and 0.998) in the range of 50% to 150% of working concentration. The recovery at 50%, 100% and 150% of working concentration level was within 98.0% to 102.0%. The range of the method is concluded that developed method is from 50% to 150% of target concentration for ciprofloxacin hydrochloride. The applicability of the proposed method was verified through the analysis of the samples and percentage recoveries in the range of 98% to 102% were obtained without any interference detected at the main peak in the chromatogram. The validated method is highly selective, simple, accurate, cost effective, and it is applicable for stability studies and routine quality-control analysis in the pharmaceutical industries.

Share and Cite:

Shrinivas, S. and Revanasiddappa, M. (2015) Analytical Stability Indicative Method Development and Validation by High Pressure Liquid Chromatography for Assay in Ciprofloxacin hydrochloride Drug Substances. American Journal of Analytical Chemistry, 6, 719-730. doi: 10.4236/ajac.2015.69069.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Drusano, G.L., Standiford, H.C., Plaisance, K., Forrest, A., Leslie, J. and Caldwell, J. (1986) Absolute Oral Bioavailability of Ciprofloxacin. Antimicrobial Agents and Chemotherapy, 30, 444-446.
[2] Hilliard, J.J., Krause, H.M., Bernstein, J.I., Fernandez, J.A., Nguyen, V., Ohemeng, K.A. and Barrett, J.F. (1995) A Comparison of Active Site Binding of 4-Quinolones and Novel Flavone Gyrase Inhibitors to DNA Gyrase. Advances in Experimental Medicine and Biology, 390, 59-69.
[3] Spivey, J.M., Cummings, D.M. and Pierson, N.R. (1996) Failure of Prostatitis Treatment Secondary to Probable Ciprofloxacin-Sucralfate Drug Interaction. Pharmacotherapy, 16, 314-316.
[4] Ball, P. (2000) Quinolone Generations: Natural History or Natural Selection? Journal of Antimicrobial Chemotherapy, 46, 17-24.
[5] Oliphant, C.M. and Green, G.M. (2002) Quinolones: A Comprehensive Review. American Family Physician, 65, 455-464.
[6] Solomkin, J.S., Mazuski, J.E., Bradley, J.S., et al. (January 2010) Diagnosis and Management of Complicated Intra-Abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clinical Infectious Diseases, 50, 133-164.
[7] Osmon, D.R., Berbari, E.F., Berendt, A.R., Lew, D., Zimmerli, W., Steckelberg, J.M., Rao, N., Hanssen, A. and Wilson, W.R. (2012) Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases, 56, e1-e25.
[8] Ritter, J.M. and Lewis, L.D. (2008) Clinical Pharmacology and Therapeutics (Textbook). A Hodder Arnold Publication. CRC Press, Boca Raton, 423-429.
[9] US Food and Drug Administration (2009) Cipro Labeling Revision 04/06/2009 Supplement 073. Retrieved 8 September 2009.
[10] Park, H., Kim, T.H. and Bark, K. (2002) Physicochemical Properties of Quinolone Antibiotics in Various Environments. European Journal of Medicinal Chemistry, 37, 443.
[11] (2011) Ciprofloxacin Hydrochloride. The American Society of Health-System Pharmacists.
[12] Mahrouse, M.A. and Elkady, E.F. (2011) Validated Spectrophotometric Methods for the Simultaneous Determination of Ciprofloxacin Hydrochloride and Metronidazole in Tablets. Chemical and Pharmaceutical Bulletin, 59, 1485-1493.
[13] Cazedey, E.C.L. and Salgado, H.R.N. (2012) Spectrophotometric Determination of Ciprofloxacin Hydrochloride in Ophthalmic Solution. Advances in Analytical Chemistry, 2, 74-79.
[14] Snyder, L.R., Kirkland, J.J. and Glajch. J.L. (1997) Practical HPLC Method Development, 2nd Edition, Wiley, Hoboken.
[15] Wu, S.-S., Chein, C.-Y. and Wen, Y.-H. (2008) Analysis of Ciprofloxacin by a Simple High-Performance Liquid Chromatography Method. Journal of Chromatographic Science, 46, 490-495.
[16] Patel, S.A., Patel, N.M. and Patel, M.M. (2006) Simultaneous Spectrophotometric Estimation of Ciprofloxacin and Ornidazole in Tablets. Indian Journal of Pharmaceutical Sciences, 68, 665-667.
[17] Patel, K.B, Thula, K.C. and Maheshwari, D.G. (2014) Stability Indicating HPLC Method for Simultaneous Estimation of Ciprofloxacin and Phenylephrine in Pharmaceutical Dosage form. Pharmacophore, 5, 262-272.
[18] Patel, N.V. and Prajapati. A.M. (2012) Q-Absorbance Ratio Spectrophotometric Method for the Simultaneous Estimation of Ciprofloxacin and Metronidazole in Their Combined Dosage Form. Journal of Pharmaceutical Science Bioscientific Research, 2, 118-122.
[19] Text and Methodology Q 2 (R1) (2011) ICH Guidelines on Validation of Analytical Procedure.
[20] Validation of Analytical Procedure Methodology (1996) ICH Harmonized Tripartite Guidelines.
[21] Text on Validation of Analytical Procedure Step-4 Q2A (1994) ICH Harmonized Tripartite Guidelines.
[22] International Conference on Harmonization (2003) Stability Testing of New Drug Substances and Products Q1A (R2). IFPMA, Geneva.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.